Some health experts have recommended that any man who receives a PSA test result that puts them in a high-risk category for prostate cancer begin taking dutasteride, a medication that has been shown to reduce the size of enlarged prostates. However, a new study published by the journal Cancer Prevention Research has found that this is not a cost-effective way to prevent the disease.
While the drug has shown some benefits to men who are at increased risk of developing prostate cancer, they are limited and outweighed by the cost, the study found. At an average annual cost of $1,400, dutasteride is an impractical solution for most men who receive elevated PSA test results.
For the study, the researchers compared the estimated lifetime cost of the drug with the projected quality and length of life for men at high risk of developing prostate cancer. They found that while dutasteride does extend the lifespan and reduce the odds of developing cancer, it only does so to a small degree. These minimal benefits do not justify the high cost of the medication, the researchers said.
"Prior to instituting a chemoprevention strategy to a large population, the utility and cost need to be well understood," said Yair Lotan, who led the study. "Whether a medication improves survival, how it affects quality of life, and what its financial implications will be are all critical issues."
Related Articles from Private MD:
News Categories:Advanced Lipid Treatment I Allergy Testing Anemia and RBC disorders Autoimmune Diseases Bariatric Lab Testing Blood and Blood Diseases Breast Cancer Detection and Tumor Markers Celiac Disease Testing Chlamydia Coagulation and blood clotting disorders Colon Diabetes DNA, Paternity and Genetic testing Drug Screening Environmental Toxin Testing Female Specific Tests Gastrointestinal Diseases General Health General Wellness Heart Health and Cholesterol Herpes HIV HIV monitoring/Treatment/Testing/Post Diagnos Hormones and Metabolism Infectious Diseases Infertility Testing-Male Infertitlity Hormone Testing Kidney Diseases Leukemia and WBC disorders Liver Liver Diseases Lyme Disease Male Specific Tests Menopause/Peri-Menopausal Diagnosis Musculoskeletal Diseases Nicotine Screening Organ Specific Testing Ovarian Prostate Sexually Transmitted Diseases Thyroid Diseases Transgender Hormone Testing-female to male Transgender Hormone Testing-Male to Female Vitamin D Deficiency-Diagnosis and Treatment
Visit the Health News Archive: Click HereBack to top